- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ABP 654
Total 5697 results
-
Global Alliance for TB Drug DevelopmentCompleted
-
Peking Union Medical College HospitalUnknown
-
MedImmune LLCCompletedAsthmaBulgaria, United Kingdom, Germany, Poland, Romania
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Jason J. Luke, MDArray BioPharmaActive, not recruitingMelanoma | Renal Cell Carcinoma | Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States
-
Unilever R&DSprim Advanced Life SciencesTerminated
-
MedImmune LLCTerminatedModerate AsthmaUnited Kingdom
-
AEON Biopharma, Inc.PPDEnrolling by invitationMigraineUnited States, Australia, Canada
-
AEON Biopharma, Inc.PPDCompletedCervical DystoniaUnited States
-
Neurocrine BiosciencesCompletedMajor Depressive DisorderUnited States, Czechia, Bulgaria, Poland, Slovakia, Sweden
-
MedImmune LLCCompletedAsthma | Healthy Subjects or VolunteersUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.Completed
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Canada, Denmark, Poland, Switzerland
-
Boryung Pharmaceutical Co., LtdCompletedHypertensionKorea, Republic of
-
University of PennsylvaniaActive, not recruitingRefractory Acute Lymphoblastic Leukemia | Chemotherapy Resistant Acute Lymphoblastic LeukemiaUnited States
-
MedImmune LLCCompleted
-
AmgenCompleted
-
MedImmune LLCCompleted
-
BTL Industries Ltd.Active, not recruiting
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States
-
Akebia TherapeuticsCompletedAnemia | Non-dialysis Dependent Chronic Kidney DiseaseJapan
-
MedImmune LLCPRA Health Sciences; Cambridge Antibody TechnologyTerminatedAsthmaNetherlands, United Kingdom, Australia, Germany, Poland
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Beijing Tongren HospitalBeijing Children's Hospital; Children's Hospital of The Capital Institute of...Recruiting
-
Eisai Inc.CompletedBreast Cancer | Breast Neoplasms | Cancer, Breast | Breast Cancer Female | Estrogen Receptor Positive Tumor | Breast Adenocarcinoma | ER Positive | Estrogen-receptor Positive Breast CancerFrance, United Kingdom, United States
-
Array Biopharma, now a wholly owned subsidiary...CompletedMyelodysplastic SyndromesUnited States
-
GigaGen, Inc.National Cancer Institute (NCI)RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Switzerland, Canada, Denmark, Poland
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
ValbiotisBioTeSys GmbHRecruitingElevated Blood PressureGermany
-
Fisher and Paykel HealthcareCompleted
-
AbbVie (prior sponsor, Abbott)Prostate Cancer Clinical Trials ConsortiumCompleted
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada
-
Array Biopharma, now a wholly owned subsidiary...CompletedMyelodysplastic SyndromesUnited States
-
Chugai Pharma USACompletedAtherosclerosis | Coronary Restenosis | Graft Occlusion, VascularUnited States
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
CStone PharmaceuticalsBlueprint Medicines CorporationCompletedHepatocellular CarcinomaChina
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Australia, United Kingdom, Germany, Ireland
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Australia, Spain, United Kingdom, France, Singapore
-
Arcutis Biotherapeutics, Inc.CompletedPlaque PsoriasisUnited States, Australia, Bulgaria, Canada
-
AbbVie (prior sponsor, Abbott)CompletedGastric CancerUnited States, Korea, Republic of
-
University of Kansas Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
AbbVie (prior sponsor, Abbott)CompletedOsteoarthritis of the KneeUnited States
-
University of ArkansasErasmus Medical Center; The Netherlands Cancer Institute; Biolitec Pharma Ltd.TerminatedSquamous Cell Carcinoma of the Head and NeckUnited States